[{"address1": "Rue Edouard Belin 12", "city": "Mont-Saint-Guibert", "zip": "1435", "country": "Belgium", "phone": "32 10 22 23 55", "website": "https://www.nyxoah.com", "industry": "Medical Instruments & Supplies", "sector": "Healthcare", "longBusinessSummary": "Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.", "fullTimeEmployees": 146, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Taub MBA", "age": 76, "title": "Co-Founder & Chairman", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 142657, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Olivier  Taelman", "age": 52, "title": "CEO & Executive Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 902099, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Loic  Moreau", "age": 42, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 523856, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bruno  Onkelinx", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mikaela  Kirkwood", "title": "Corporate Communication & Investor Relations Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. An  Moonen", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Inge  Vanwittenbergh", "title": "Global Human Resource Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David M. DeMartino", "title": "Chief Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Remi  Renard", "title": "Chief of Staff", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeyakumar  Subbaroyan", "title": "Chief Clinical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.25, "open": 8.1, "dayLow": 7.97, "dayHigh": 8.16, "regularMarketPreviousClose": 8.25, "regularMarketOpen": 8.1, "regularMarketDayLow": 7.97, "regularMarketDayHigh": 8.16, "beta": 0.613, "forwardPE": -4.6511626, "volume": 16186, "regularMarketVolume": 16186, "averageVolume": 15331, "averageVolume10days": 6350, "averageDailyVolume10Day": 6350, "marketCap": 282962400, "fiftyTwoWeekLow": 4.0, "fiftyTwoWeekHigh": 20.0, "priceToSalesTrailing12Months": 59.048916, "fiftyDayAverage": 8.22298, "twoHundredDayAverage": 9.077595, "currency": "USD", "enterpriseValue": 209942112, "floatShares": 13197175, "sharesOutstanding": 34373000, "sharesShort": 48034, "sharesShortPriorMonth": 58350, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0014, "heldPercentInsiders": 0.42575002, "heldPercentInstitutions": 0.25191, "shortRatio": 4.73, "shortPercentOfFloat": 0.0026, "bookValue": 3.495, "priceToBook": 2.2889843, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -43535000, "trailingEps": -1.65, "forwardEps": -1.72, "enterpriseToRevenue": 43.811, "enterpriseToEbitda": -4.502, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "NYXH", "underlyingSymbol": "NYXH", "shortName": "Nyxoah SA", "longName": "Nyxoah S.A.", "firstTradeDateEpochUtc": 1619616600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "067cdc20-d2e6-3884-af4a-437fe8703370", "gmtOffSetMilliseconds": -14400000, "currentPrice": 8.0, "targetHighPrice": 19.9, "targetLowPrice": 12.93, "targetMeanPrice": 16.91, "targetMedianPrice": 17.91, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 77785000, "totalCashPerShare": 2.263, "ebitda": -46634000, "totalDebt": 12743000, "quickRatio": 5.081, "currentRatio": 5.473, "totalRevenue": 4792000, "debtToEquity": 10.607, "revenuePerShare": 0.164, "returnOnAssets": -0.20361, "returnOnEquity": -0.36938, "freeCashflow": -38000624, "operatingCashflow": -45893000, "revenueGrowth": -0.304, "grossMargins": 0.625, "operatingMargins": -17.2594, "financialCurrency": "EUR", "trailingPegRatio": null, "__fetch_time": "2024-09-01"}]